Marc Abreu

Marc Abreu is a doctor and surgeon with an extensive academic career who, in addition to his medical degree and residency and title of specialist in ophthalmology at the Escola Paulista de Medicina da Universidade Federal de São Paulo (Unifesp), in Brazil, has degrees and specializations at the Schools of Medicine at the Universities of Indiana, Pittsburgh, Harvard and Yale, also serving as a professor at the Harvard University School of Medicine and the Yale University School of Medicine, where he also served as co-director of the Interdisciplinary Research Group on MTB.

Dr. Marc is an expert in brain thermodynamics and thermoregulatory frequencies, pioneering in delineating the radiation signature of the glucose molecule. He designed and patented BTT (Brain Thermal Tunnel) technology based on his biological discovery of the brain thermal tunnel at Yale University, which allowed, for the first time in history, the continuous and non-invasive measurement of human brain temperature.

This discovery led to the invention and patent of the Abreu BTT 700 System, approved by the FDA. Dr. Marc Abreu is medical director of the BTT Medical Institute, where, in addition to cancer patients, he has treated patients with neurodegeneration, including Alzheimer's disease, Parkinson's disease, ataxia, Huntington's disease, motor neurone disease (ALS), atrophy of multiple systems, in addition to multiple sclerosis, epilepsy and other neurological diseases, based on the modulation of cerebral thermodynamics and thermoregulatory frequencies.